LobbyingUt Southwestern Medical Center lobbying by quarter
Ut Southwestern Medical Center's latest lobbying report covers Q2 2026, at $142.1K. The four quarters Q4 2025–Q3 2026 total $425.2K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Medicare/Medicaid.
Ut Southwestern Medical Center
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $425.2K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $112K | 1 |
| Q1 2023 | $106.2K | 1 |
| Q2 2023 | $113.8K | 1 |
| Q3 2023 | $115.6K | 1 |
| Q4 2023 | $117.1K | 1 |
| Q1 2024 | $116.7K | 1 |
| Q2 2024 | $115.7K | 1 |
| Q3 2024 | $115.9K | 1 |
| Q4 2024 | $119.9K | 1 |
| Q1 2025 | $131.8K | 1 |
| Q2 2025 | $128K | 1 |
| Q3 2025 | $127K | 1 |
| Q4 2025 | $139.7K | 1 |
| Q1 2026 | $143.4K | 1 |
| Q2 2026 | $142.1K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$768.9K · 15 reports
- Medicare and Medicaid$768.9K · 15 reports
- Health issues$307K · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Health & Human Services, Dept of (HHS)8 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseUt Southwestern Medical Center | $1.8M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $142.1K |
| 04/20for Q1 | In-house | $143.4K |
| 01/20for Q4 2025 | In-house | $139.7K |
| 25/10/20for Q3 2025 | In-house | $127K |
| 25/07/21for Q2 2025 | In-house | $128K |
| 25/04/22for Q1 2025 | In-house | $131.8K |
| 25/01/21for Q4 2024 | In-house | $119.9K |
| 24/10/21for Q3 2024 | In-house | $115.9K |
| 24/07/22for Q2 2024 | In-house | $115.7K |
| 24/04/22for Q1 2024 | In-house | $116.7K |
| 24/04/22for Q1 2024 | In-house | $116.6K |
| 24/01/22for Q4 2023 | In-house | $117.1K |
| 23/10/19for Q3 2023 | In-house | $115.6K |
| 23/07/20for Q2 2023 | In-house | $113.8K |
| 23/04/20for Q1 2023 | In-house | $106.2K |
| 23/01/19for Q4 2022 | In-house | $112K |